Sugi Predict

Sugi Predict / Compounds / SCHEMBL2469717

SCHEMBL2469717

SCHEMBL2469717

COCCOC(=O)c1cc(O)c2ccc(Br)cc2c1C

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TSHR P16473 1/20 0.47
▸ ATM Q13315 1/20 0.43
▸ ALDH1A1 P00352 3/20 0.41
▸ SMN1; SMN2 Q16637 1/20 0.41
▸ GABRA1 P14867 1/20 0.40
▸ GABRB1 P18505 1/20 0.40
▸ GABRA3 P34903 1/20 0.40
▸ GABRB2 P47870 1/20 0.40
▸ SERPINE1 P05121 1/20 0.39
▸ LMNA P02545 2/20 0.39
▸ HPGD P15428 2/20 0.38
▸ MAPK1 P28482 1/20 0.38
▸ KMT2A Q03164 2/20 0.36
▸ NR4A2 P43354 1/20 0.36
▸ KDM4E B2RXH2 1/20 0.36
▸ MEN1 O00255 1/20 0.36
▸ TP53 P04637 1/20 0.36
▸ GLA P06280 1/20 0.36
▸ GAA P10253 1/20 0.36
▸ CASP1 P29466 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2469996 0.84 NR4A2 (0.51) TSHRALDH1A1SMN1; SMN2LMNANR4A2
SCHEMBL2469267 0.81 TSHR (0.43) TSHRALDH1A1SERPINE1LMNAHPGD
SCHEMBL2466414 0.76 RXFP1 (0.46) ALDH1A1HPGDKMT2AKDM4EMEN1
SCHEMBL15214803 0.71 NR4A2 (0.52) TSHRALDH1A1SMN1; SMN2LMNAKMT2A
SCHEMBL1531831 0.70 TSHR (0.52) TSHRALDH1A1SMN1; SMN2LMNANR4A2
SCHEMBL14664450 0.69 TSHR (0.61) TSHRALDH1A1SERPINE1HPGDKMT2A
SCHEMBL2147020 0.68 TSHR (0.56) TSHRALDH1A1SERPINE1HPGDKMT2A
SCHEMBL3801132 0.68 TSHR (0.56) TSHRALDH1A1SERPINE1HPGDKMT2A
SCHEMBL2469719 0.68 LDHA (0.39) ALDH1A1SMN1; SMN2KMT2AKDM4EMEN1
SCHEMBL7092473 0.67 CA12 (0.68) TSHRALDH1A1SERPINE1HPGDKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-105199708-B Photochromic compounds 光学转变公司 2020-10-27 — — CN disclosed
EP-2370420-B9 PHOTOCHROMIC COMPOUNDS TRANSITIONS OPTICAL INC (US) 2019-11-13 — — EP disclosed
EP-2370420-B1 PHOTOCHROMIC COMPOUNDS TRANSITIONS OPTICAL INC (US) 2019-05-22 — — EP disclosed
US-20180291007-A1 Photochromic Compounds TRANSITIONS OPTICAL, INC. 2018-10-11 — — US disclosed
US-20180291009-A1 Photochromic Compounds TRANSITIONS OPTICAL, INC. 2018-10-11 — — US disclosed
US-20180291008-A1 Photochromic Compounds TRANSITIONS OPTICAL, INC. 2018-10-11 — — US disclosed
US-10005763-B2 Photochromic compounds TRANSITIONS OPTICAL, INC. (US) 2018-06-26 — — US disclosed
US-10000472-B2 Photochromic compounds TRANSITIONS OPTICAL, INC. (US) 2018-06-19 — — US disclosed
US-20160333262-A1 Photochromic Compounds TRANSITIONS OPTICAL, INC. 2016-11-17 — — US disclosed
US-20160332995-A1 Photochromic Comounds TRANSITIONS OPTICAL, INC. 2016-11-17 — — US disclosed
CN-105199708-A Photochromic compounds TRANSITIONS OPTICAL INC 2015-12-30 — — CN disclosed
CN-102272114-B Photochromic compounds TRANSITIONS OPTICAL, INC. (US) 2015-09-02 — — CN disclosed
US-20140154514-A1 PHOTOCHROMIC COMPOUNDS TRANSITIONS OPTICAL, INC. (US) 2014-06-05 — — US disclosed
US-8705160-B2 Photochromic compounds TRANSITIONS OPTICAL, INC. (US) 2014-04-22 — — US disclosed
US-20120200907-A1 PHOTOCHROMIC COMPOUNDS TRANSITIONS OPTICAL, INC. (US) 2012-08-09 — — US disclosed
US-8211338-B2 Photochromic compounds TRANSITIONS OPTICAL, INC (US) 2012-07-03 — — US disclosed
CN-102272114-A Photochromic compounds — 2011-12-07 — — CN disclosed
EP-2370420-A1 PHOTOCHROMIC COMPOUNDS TRANSITIONS OPTICAL, INC. (US) 2011-10-05 — — EP disclosed
WO-2010065393-A1 PHOTOCHROMIC COMPOUNDS TRANSITIONS OPTICAL, INC. (US) 2010-06-10 — — WO disclosed
US-20090309076-A1 PHOTOCHROMIC COMPOUNDS TRANSITIONS OPTICAL, INC. (US) 2009-12-17 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (9 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180291007-A1 Photochromic Compounds CCR4, CCR8, CBR3 TSHR 196/4885ATM 2282/4885ALDH1A1 1805/4885
US-20160332995-A1 Photochromic Comounds CCR4, CCR3, CCR8 TSHR 239/4885ATM 2453/4885ALDH1A1 1767/4885
US-10005763-B2 Photochromic compounds CCR4, CCR8, CBR3 TSHR 196/4885ATM 2265/4885ALDH1A1 1782/4885
US-20180291008-A1 Photochromic Compounds CCR4, CBR3, CCR8 TSHR 180/4885ATM 2348/4885ALDH1A1 1817/4885
US-20160333262-A1 Photochromic Compounds CCR4, CCR8, CBR3 TSHR 196/4885ATM 2265/4885ALDH1A1 1782/4885
US-20180291009-A1 Photochromic Compounds CCR4, CCR8, CBR3 TSHR 188/4885ATM 2281/4885ALDH1A1 1831/4885
US-10000472-B2 Photochromic compounds CCR4, CCR8, CBR3 TSHR 196/4885ATM 2265/4885ALDH1A1 1782/4885
US-20120200907-A1 PHOTOCHROMIC COMPOUNDS CCR4, CCR8, CBR3 TSHR 205/4885ATM 2315/4885ALDH1A1 1771/4885
US-20090309076-A1 PHOTOCHROMIC COMPOUNDS CCR4, CCR8, CBR3 TSHR 196/4885ATM 2265/4885ALDH1A1 1782/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.